DNA Nanotherapeutics Platform

About Parabon Nanolabs

Parabon NanoLabs is a privately-held US biotech firm pioneering the integration of computation and genetics to create next-generation DNA-based products. The company has a dual focus: a therapeutics-oriented DNA nanotech platform for drug design and a highly visible forensic services division offering DNA phenotyping, genetic genealogy, and kinship analysis to law enforcement. While its forensic services generate public case studies and likely early revenue, its therapeutic platform appears to be in a pre-clinical or research-stage development. Parabon's unique position bridges the biotechnology and forensic science markets, though it faces distinct challenges in each domain.